Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Renner

Showing results (131-140 of 179) with videos related to

Pageof 18
Sort By:
Swiss Medical Weekly|November 20, 2003
Twenty-four vs. forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis CBarbara S E August-Jörg, Jan Borovicka, Jean-François Dufour, et al.
Molecular Biology of the Cell|February 10, 2004
c-Fos activated phospholipid synthesis is required for neurite elongation in differentiating PC12 cellsGermán A Gil, Daniela F Bussolino, Maximiliano M Portal, et al.
Annals of Surgery|October 28, 2009
Live donor liver transplantation in high MELD score recipientsMarkus Selzner, Arash Kashfi, Mark S Cattral, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|November 18, 2006
Recurrent hepatitis C post-transplantation: where are we now and where do we go from here? A report from the Canadian transplant hepatology workshopKymberly D S Watt, Kelly Burak, Marc Deschênes, et al.
Hepatology (Baltimore, Md.)|February 5, 2002
Interferon and amantadine in naive chronic hepatitis C: a double-blind, randomized, placebo-controlled trialBeat Helbling, Ivan Stamenic, Francesco Viani, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 31, 2009
Financial, vocational, and interpersonal impact of living liver donationSusan Holtzman, Lesley Adcock, Derek A Dubay, et al.
Transplantation|May 18, 2011
Comparison of hospitalized solid organ transplant recipients and nonimmunocompromised patients with pandemic H1N1 infection: a retrospective cohort studyBrian J Minnema, Mehul Patel, Coleman Rotstein, et al.
Annals of Transplantation|January 16, 2015
Sustained virological response to antiviral therapy in a randomized trial of cyclosporine versus tacrolimus in liver transplant patients with recurrent hepatitis C infectionChristophe Duvoux, Federico Villamil, Eberhard L Renner, et al.
Journal of Hepatology|September 1, 1996
Fixed versus titrated interferon-alpha 2B in chronic hepatitis C. A randomized controlled multicenter trial. The Swiss Association for the Study of the LiverJ Reichen, L Bianchi, H Bühler, et al.
East African Medical Journal|September 20, 2005
Cryptosporidium oocysts in Ghanaian AIDS patients with diarrhoeaA Adjei, M Lartey, T K Adiku, et al.
Pageof 18

Showing results (131-140 of 179) with videos related to

Sort By:
Pageof 18
Swiss Medical Weekly|November 20, 2003
Twenty-four vs. forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis CBarbara S E August-Jörg, Jan Borovicka, Jean-François Dufour, et al.
Molecular Biology of the Cell|February 10, 2004
c-Fos activated phospholipid synthesis is required for neurite elongation in differentiating PC12 cellsGermán A Gil, Daniela F Bussolino, Maximiliano M Portal, et al.
Annals of Surgery|October 28, 2009
Live donor liver transplantation in high MELD score recipientsMarkus Selzner, Arash Kashfi, Mark S Cattral, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|November 18, 2006
Recurrent hepatitis C post-transplantation: where are we now and where do we go from here? A report from the Canadian transplant hepatology workshopKymberly D S Watt, Kelly Burak, Marc Deschênes, et al.
Hepatology (Baltimore, Md.)|February 5, 2002
Interferon and amantadine in naive chronic hepatitis C: a double-blind, randomized, placebo-controlled trialBeat Helbling, Ivan Stamenic, Francesco Viani, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 31, 2009
Financial, vocational, and interpersonal impact of living liver donationSusan Holtzman, Lesley Adcock, Derek A Dubay, et al.
Transplantation|May 18, 2011
Comparison of hospitalized solid organ transplant recipients and nonimmunocompromised patients with pandemic H1N1 infection: a retrospective cohort studyBrian J Minnema, Mehul Patel, Coleman Rotstein, et al.
Annals of Transplantation|January 16, 2015
Sustained virological response to antiviral therapy in a randomized trial of cyclosporine versus tacrolimus in liver transplant patients with recurrent hepatitis C infectionChristophe Duvoux, Federico Villamil, Eberhard L Renner, et al.
Journal of Hepatology|September 1, 1996
Fixed versus titrated interferon-alpha 2B in chronic hepatitis C. A randomized controlled multicenter trial. The Swiss Association for the Study of the LiverJ Reichen, L Bianchi, H Bühler, et al.
East African Medical Journal|September 20, 2005
Cryptosporidium oocysts in Ghanaian AIDS patients with diarrhoeaA Adjei, M Lartey, T K Adiku, et al.
Pageof 18